To The Moon

$SUPER MICRO COMPUTER INC(SMCI)$ $Tesla Motors(TSLA)$ Bullish $NVIDIA(NVDA)$ Bullish I’m examining $SMCI through two frameworks right now, and they remain decisively out of sync. Price behaviour reflects fatigue after an extended contraction phase. Product architecture, hyperscale demand, and long-dated options positioning point toward deliberate accumulation. 🧭 Structure Check, Compression Before Commitment On the technical side, the 4H and 30-minute charts remain confined within descending Keltner and Bollinger bands, but the mechanics have changed. Volatility is compressing, lower bands are stabilising, and the $29 zone continues to absorb

$S&P 500(.SPX)$ $Invesco QQQ(QQQ)$  $Meta Platforms, Inc.(META)$  31Dec25 🇺🇸 | 01Jan26 🇳🇿 Market Pulse I’m closing the books on 2025 with a very clear message from price, breadth, and cross-asset behaviour. The final session was decisively risk-off, even as the year itself finished structurally strong. Markets closed red, with the $DJI, $SPX, and $IXIC logging a 4th straight daily loss. The Nasdaq slipped into the red for December, while the Dow notched its 8th straight monthly win. Still, all three capped a 3rd straight positive quarter and year, a classic late-cycle tell. Market breadth was decisively bearish to close the year. On the NYS

$Tesla Motors(TSLA)$ Bullish $Taiwan Semiconductor Manufacturing(TSM)$ Bullish $NVIDIA(NVDA)$ Bullish 31Dec25 🇺🇸 | 01Jan26 🇳🇿  I’m calling this market exactly as it traded, not as it was supposed to. The Grinch is no longer stealing Christmas, he’s cancelling it. The Santa Rally script failed, volatility took control, and $TSLA became the clearest expression of a regime shift that punished complacency and rewarded structure. That Grinch board isn’t satire. It’s a ledger. Happy New Year to all Tigers and traders 🎆 I’m stepping into 2026 focused on discipline, data, and positioning, not folklore. 🎅❌ Santa Rally Failure: When the Grinch

$SPROTT JUNIOR COPPER MINERS ETF(COPJ)$  $SPDR Portfolio S&P 500 ETF(SPYM)$  $NEOS Nasdaq 100 High Income ETF(QQQI)$  I’m watching ETFs again. Not because I’m chasing beta, and not because I prefer simplification, but because ETFs are the earliest visible footprint of how institutions reposition before the broader narrative catches up. After decades watching capital flows dictate cycles, one principle holds. When ETF leadership changes, portfolios have already moved. That’s why this matters. Eric Balchunas at Bloomberg has published his “26 ETFs to Watch in

$Tesla Motors(TSLA)$ $T-Rex 2x Inverse Tesla Daily Target ETF(TSLZ)$  $Direxion Daily TSLA Bull 2X Shares(TSLL)$  🔥🎅🍔 The Grinch Meets the Tesla Burger Index: Price Weakness, Ecosystem Strength 🍔⚡️📉 Grinch still cooking 🔥📉 🔴🔴🔴🔴🔴 five straight red days through what is statistically meant to be the Santa Rally window. That’s uncomfortable, but it’s not unprecedented. The last time this exact setup printed, $TSLA still managed to gap down another $19 the following session. I’m relaxed. That’s a rare stat, not a thesis failure. The tape tells a clear short-term story. Liquidity has thinned into year-end, gamma support has softened, and intraday bo

$NVIDIA(NVDA)$  $Tesla Motors(TSLA)$  $FTAI AVIATION LTD(FTAI)$  30Dec25 🇺🇸 | 31Dec25 🇳🇿🥳 ALLLLL RED. And not the Santa kinda red! 🔴🔴🔴🔴🔴 I’m framing this session as measured de-risking rather than emotional liquidation. Internals support that view, and the tape reads like late-year positioning, not a regime shift. I’m noting that after trading red most of the day, $IXIC and $SPX closed modestly lower, while $DJI fell 94 points. All three logged a third straight daily loss as tech struggled to bounce from Monday’s drop. I’m stating this plainly, the market slipped again today, but breadth wasn’t ugly. 🔻 Down movers I’m watching pressure pe

$NVIDIA(NVDA)$ $Tesla Motors(TSLA)$  $iShares Silver Trust(SLV)$  Today’s Most Active Stocks and Options 30Dec25 🇺🇸 | 31Dec25 🇳🇿🥳 Top 5 symbols controlling the tape: $NVDA $TSLA $SLV $MU $VOO 📊 Flow and Volume, Big Money Has Already Voted I’m watching $NVDA dominate activity with 286,134 total contracts and a +27,892 net imbalance across stock and options. That is not speculative churn. That is capital rotating with intent. Structure remains intact, momentum rebuilt, and prior downside attempts resolved into a clean bear trap. Flow has flipped back toward leadership. 🧠 M&A Optionality, Talent Over Headlines NVIDIA is reportedly in advanced

$Meta Platforms, Inc.(META)$ $NVIDIA(NVDA)$  $Intel(INTC)$  📊🧠🚀 $META Compression, Pattern Reset, and a Strategic AI Inflection 🚀🧠📊 I’m reviewing all charts together, including the full pattern trading structure, and this is one of those moments where the signal is quietly stronger than the headlines. While much of the AI space is chasing narrative momentum, $META is doing something far more interesting structurally. I’m watching price coil tightly inside the $655 to $666.80 blue bands. This is not random chop and it is not late cycle indecision. This is controlled compression sitting directl

$PulteGroup(PHM)$ $Toll Brothers(TOL)$  $Lennar(LEN)$  📉🏗️📊 PHM Pullback Into the 320DMA, Noise or Opportunity? 📊🏗️📉 I’m watching PulteGroup $PHM ease about −1.2% as homebuilders cool after the hotter Case-Shiller print. That macro pressure is clear, but it’s also well flagged and broadly priced across the group. I’m far more interested in where price is landing. PHM is pulling back into its 320DMA around $117–118, a zone that has historically acted as a stabilisation area rather than a breakdown trigger. About half the time, tests of this long-term average have resolved higher, particularly when the broader trend structure remains intact. I’m no

$Ultragenyx Pharmaceutical(RARE)$ $Spdr S&P Biotech Etf(XBI)$  $iShares Biotechnology ETF(IBB)$  🧬🎯 Brittle Endpoint, Resilient Helix 🎯🧬 When a price cut sharpens the aim, not the thesis 🚨📰 Just in: $RARE proves you can put the target on a diet without starving the thesis. 🏦 Wells Fargo cut its price target on $RARE to $45 from $65 while maintaining Overweight. I read this as probability discipline, not loss of conviction. At roughly $19.72, the revised framework still implies about 128% upside, reframing the move as risk calibration rather than thesis erosion. ✂️ The reset followed Ultragenyx’s setrusumab miss in osteogenesis imperfecta, wh